Estimating the indirect costs associated with adenocarcinoma or squamous cell carcinoma of the oesophagus in Switzerland: evidence from a cross-sectional survey
Oesophageal cancer in Switzerland affects patients' professional and personal lives, resulting in lost time and informal caregiving, leading to societal costs.
Authors
- Alexander Siebenhüner (ORCID: https://orcid.org/0000-0002-5404-2383)
- Miklos Pless (ORCID: https://orcid.org/0000-0001-5121-4402)
- Andreas N. WICKI (ORCID: https://orcid.org/0000-0002-2924-8080)
- C. Oniangue-Ndza
- Paola Salari (ORCID: https://orcid.org/0000-0003-3757-6081)
- Sandro Stoffel (ORCID: https://orcid.org/0000-0002-0124-0941)
- Arjun Bhadhuri (ORCID: https://orcid.org/0000-0003-1220-0731)
- Matthias Schwenkglenks (ORCID: https://orcid.org/0000-0001-7217-1173)
- Letizia Deantonio (ORCID: https://orcid.org/0000-0002-2812-2283)
- Dieter Koeberle (ORCID: https://orcid.org/0000-0002-2742-0115)
- Thibaud Koessler (ORCID: https://orcid.org/0000-0001-9196-9076)
- Tim Kahl
Institutions
- Bristol-Myers Squibb (Germany) (DE)
- University of Basel (CH)
- University of Zurich (CH)
- Hôpital Beau-Séjour (CH)
- Ente Ospedaliero Cantonale (CH)
- Klinik Hirslanden (CH)
- Kantonsspital Winterthur (CH)
- University Hospital of Zurich (CH)
- St. Claraspital (CH)
- Kantonsspital Graubünden (CH)
- Università della Svizzera italiana (CH)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-090401
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Bristol-Myers Squibb